Contrast-Free Magnetic Resonance Imaging for Breast Disease

RecruitingOBSERVATIONAL
Enrollment

1,030

Participants

Timeline

Start Date

July 6, 2021

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Breast CancerBreast Diseases
Interventions
DIAGNOSTIC_TEST

Outpatient MRI

"Participation in the study includes up to a maximum of 2 study visits. The visits will include clinical measurements (height, weight, blood pressure), blood tests, MRI scan and patient symptoms and experience questionnaires.~There will be no medical interventions as part of the study. All participants will receive standard-of-care by their healthcare provider/s. With the participant's consent, the participant's primary care physician will be made aware of their participation in the study. Furthermore, participants will be informed of any structural abnormalities found in the MRI scan (e.g. abnormal vessels, haemangioma, tumour, cyst, among others) and abnormal blood test results as these may have clinical implications. These will be managed by the routine clinical care team as part of standard care."

Trial Locations (1)

OX4 2LL

RECRUITING

Gemini One, Oxford

All Listed Sponsors
lead

Perspectum

INDUSTRY